Conference abstract · 2013
Conference abstractPublished 2018
Alternative splicing in diabetic nephropathy and other chronic kidney diseases
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Alternative splicing (AS) has emerged in the post-genomic era as one of the main drivers of proteome diversity with at least 94% of multi-exon genes being alternatively spliced in humans. AS is therefore, one of the main control mechanisms for cell phenotype and a process deregulated in disease. Numerous reports describe pathogenic mutations in splice factors, splice sites or regulatory sequences. Additionally, in many cases there is an abnormal proportion of splice isoforms (or novel isoforms) in disease compared to the physiological pattern, without an apparent driver mutation. It has therefore become essential to study how AS is regulated in physiology, how it contributes to pathogenesis and whether we can manipulate faulty splicing for therapeutic advantage. While the disease most commonly linked to deregulation of AS in several genes is cancer, there are many in-depth reports of pathogenic splice variants in diseases ranging from neuromuscular disorders to diabetes or cardiomyopathies. In recent years, a plethora of splice variants have been implicated in chronic kidney diseases as well. Examples of these and ideas on how to manipulate them for therapeutic benefit will be presented in this talk.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2018
Features of Lipid Metabolism and Level of Pro-inflammatory Cytokines in Patients with Type-2 Diabetes and with Diabetic Nephropathy Depending on the Stage of Chronic Kidney Disease
Short communication · 31 Jul 2020
Diabetic Nephropathy: Symptoms and Treatment of Diabetic Kidney Disease
Conference abstract · 2018
SINGLE NUCLEOTIDE POLYMORPHISMS AT ERYTHROPOIETIN, SUPEROXIDE DISMUTASE 1, SPLICING FACTOR, ARGININE/SERIN-RICH 15 AND PLASMACYTOMA VARIANT TRANSLOCATION GENES ASSOCIATION WITH DIABETIC NEPHROPATHY
Conference abstract · 3 Nov 2015
Therapeutic manipulation of splicing in diabetic nephropathy
More from this journal
The newest in Journal of Diabetes & Metabolism.
Rapid communication · 29 May 2025
Community diabetes prevention: Effective, global impact
Rapid communication · 29 May 2025
Genetic and epigenetic markers for gdm risk
Short communication · 29 May 2025
Metabolic syndrome: Diet, timed eating, supplements
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Diabetes & Metabolism
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Sebastian Oltean”
